236 related articles for article (PubMed ID: 37261361)
1. Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy.
Rupp L; Resag A; Potkrajcic V; Warm V; Wehner R; Jöhrens K; Bösmüller H; Eckert F; Schmitz M
Front Immunol; 2023; 14():1185197. PubMed ID: 37261361
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma.
Rupp L; Dietsche I; Kießler M; Sommer U; Muckenhuber A; Steiger K; van Eijck CWF; Richter L; Istvanffy R; Jäger C; Friess H; van Eijck CHJ; Demir IE; Reyes CM; Schmitz M
Front Immunol; 2024; 15():1378190. PubMed ID: 38629072
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral NKp46
Cruz SM; Sholevar CJ; Judge SJ; Darrow MA; Iranpur KR; Farley LE; Lammers M; Razmara AM; Dunai C; Gingrich AA; Persky J; Mori H; Thorpe SW; Monjazeb AM; Murphy WJ; Canter RJ
Front Immunol; 2023; 14():1230534. PubMed ID: 37545516
[TBL] [Abstract][Full Text] [Related]
4. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
5. Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells.
Nyström H; Jönsson M; Nilbert M; Carneiro A
Acta Oncol; 2023 Jan; 62(1):33-39. PubMed ID: 36786033
[TBL] [Abstract][Full Text] [Related]
6. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract][Full Text] [Related]
8. Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Smolle MA; Herbsthofer L; Goda M; Granegger B; Brcic I; Bergovec M; Scheipl S; Prietl B; El-Heliebi A; Pichler M; Gerger A; Posch F; Tomberger M; López-García P; Feichtinger J; Baumgartner C; Leithner A; Liegl-Atzwanger B; Szkandera J
Oncoimmunology; 2021 Mar; 10(1):1896658. PubMed ID: 33763294
[TBL] [Abstract][Full Text] [Related]
9. Combined Consideration of Tumor-Associated Immune Cell Density and Immune Checkpoint Expression in the Peritumoral Microenvironment for Prognostic Stratification of Non-Small-Cell Lung Cancer Patients.
Yang Y; Yang X; Wang Y; Xu J; Shen H; Gou H; Qin X; Jiang G
Front Immunol; 2022; 13():811007. PubMed ID: 35222387
[TBL] [Abstract][Full Text] [Related]
10. Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial.
Issels RD; Noessner E; Lindner LH; Schmidt M; Albertsmeier M; Blay JY; Stutz E; Xu Y; Buecklein V; Altendorf-Hofmann A; Abdel-Rahman S; Mansmann U; von Bergwelt-Baildon M; Knoesel T
Eur J Cancer; 2021 Oct; 158():123-132. PubMed ID: 34666214
[TBL] [Abstract][Full Text] [Related]
11. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer.
Zhu H; Roelands J; Ahmed EI; Stouten I; Hoorntje R; van Vlierberghe RLP; Ijsselsteijn ME; Lei X; de Miranda NFCC; Tollenaar RAEM; Vahrmeijer AL; Bedognetti D; Hendrickx WRL; Kuppen PJK
Front Immunol; 2024; 15():1293618. PubMed ID: 38375478
[TBL] [Abstract][Full Text] [Related]
12. Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcomas.
Eckert F; Gani C; Kluba T; Mayer F; Kopp HG; Zips D; Bamberg M; Müller AC
Strahlenther Onkol; 2013 Jun; 189(6):482-5. PubMed ID: 23604183
[TBL] [Abstract][Full Text] [Related]
13. T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study.
Smolle MA; Herbsthofer L; Granegger B; Goda M; Brcic I; Bergovec M; Scheipl S; Prietl B; Pichler M; Gerger A; Rossmann C; Riedl J; Tomberger M; López-García P; El-Heliebi A; Leithner A; Liegl-Atzwanger B; Szkandera J
Br J Cancer; 2021 Aug; 125(5):717-724. PubMed ID: 34127811
[TBL] [Abstract][Full Text] [Related]
14. The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma- does it influence prognosis?
Fromm J; Klein A; Kirilova M; Lindner LH; Nachbichler S; Holzapfel BM; Goller SS; Knösel T; Dürr HR
BMC Cancer; 2024 Mar; 24(1):303. PubMed ID: 38448852
[TBL] [Abstract][Full Text] [Related]
15. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
[TBL] [Abstract][Full Text] [Related]
16. Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases.
Lu BY; Gupta R; Aguirre-Ducler A; Gianino N; Wyatt H; Ribeiro M; Chiang VL; Contessa JN; Adeniran AJ; Jilaveanu LB; Kluger HM; Schalper KA; Goldberg SB
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34670827
[TBL] [Abstract][Full Text] [Related]
17. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
[TBL] [Abstract][Full Text] [Related]
18. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.
Boudin L; de Nonneville A; Finetti P; Mescam L; Le Cesne A; Italiano A; Blay JY; Birnbaum D; Mamessier E; Bertucci F
J Transl Med; 2022 Oct; 20(1):464. PubMed ID: 36221119
[TBL] [Abstract][Full Text] [Related]
19. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
Starzer AM; Berghoff AS; Hamacher R; Tomasich E; Feldmann K; Hatziioannou T; Traint S; Lamm W; Noebauer-Huhmann IM; Furtner J; Müllauer L; Amann G; Bauer S; Schildhaus HU; Preusser M; Heller G; Brodowicz T
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762319
[TBL] [Abstract][Full Text] [Related]
20. Postoperative complications and oncologic outcomes after multimodal therapy of localized high risk soft tissue sarcoma.
Potkrajcic V; Kolbenschlag J; Sachsenmaier S; Daigeler A; Ladurner R; Golf A; Gani C; Zips D; Paulsen F; Eckert F
Radiat Oncol; 2022 Dec; 17(1):210. PubMed ID: 36544149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
